FFNCX
Price
$13.66
Change
+$0.02 (+0.15%)
Updated
Jul 25 closing price
Net Assets
2.3B
VSCGX
Price
$21.67
Change
+$0.03 (+0.14%)
Updated
Jul 25 closing price
Net Assets
10.49B
Interact to see
Advertisement

FFNCX vs VSCGX

Header iconFFNCX vs VSCGX Comparison
Open Charts FFNCX vs VSCGXBanner chart's image
Fidelity Advisor Asset Manager 40% C
Price$13.66
Change+$0.02 (+0.15%)
VolumeN/A
Net Assets2.3B
Vanguard LifeStrategy Cnsrv Gr I
Price$21.67
Change+$0.03 (+0.14%)
VolumeN/A
Net Assets10.49B
FFNCX vs VSCGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FFNCX vs. VSCGX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFNCX is a Buy and VSCGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCGX has more cash in the bank: 10.5B vs. FFNCX (2.3B). VSCGX pays higher dividends than FFNCX: VSCGX (3.03) vs FFNCX (1.61). FFNCX was incepted earlier than VSCGX: FFNCX (18 years) vs VSCGX (31 years). FFNCX (1.53) is less costly to investors than VSCGX (0.12). FFNCX is a more actively managed with annual turnover of: 13.00 vs. VSCGX (5.00). FFNCX has a lower initial minimum investment than VSCGX: FFNCX (0) vs VSCGX (3000). FFNCX annual gain was more profitable for investors over the last year : 9.02 vs. VSCGX (5.63). FFNCX return over 5 years is better than : 18.17 vs. VSCGX (9.13).
FFNCXVSCGXFFNCX / VSCGX
Total Expense Ratio1.530.121,275%
Annual Report Gross Expense Ratio1.530.121,275%
Fund Existence18 years31 years-
Gain YTD6.6607.16293%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRA500N/A-
Net Assets2.3B10.5B22%
Annual Yield % from dividends1.613.0353%
Returns for 1 year9.025.63160%
Returns for 3 years18.4814.51127%
Returns for 5 years18.179.13199%
Returns for 10 years36.2437.3197%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPCX12.960.07
+0.54%
Saratoga Health & Biotechnology C
SHSCX45.890.22
+0.48%
BlackRock Health Sciences Opps Inv C
TLASX12.130.05
+0.41%
Transamerica Large Core ESG R6
FCUDX20.110.08
+0.40%
NYLI PineStone U.S. Equity Class R6
NSGAX23.160.07
+0.30%
Columbia Select Large Cap Equity A